The Oncosearch | Oncotarget

Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells Research Paper

Chengke Luo, Zhenghao Deng, Lan Li, Frederic Clayton, Alexander L. Chen, Ran Wei, Rodney Miles, Deborah M. Stephens, Martha Glenn, Xiyang Wang, Peter E. Jensen, Xinjian Chen

Published Feb 7, 2016 · Vol. 7, No. 11 · pp. 12806-12822

Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis Research Paper

Madison Black, Ivraym B. Barsoum, Peter Truesdell, Tiziana Cotechini, Shannyn K. Macdonald-Goodfellow, Margaret Petroff, D. Robert Siemens, Madhuri Koti, Andrew W.B. Craig, Charles H. Graham

Published Feb 7, 2016 · Vol. 7, No. 9 · pp. 10557-10567

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study Research Paper

Huimin Bai, Guisha Sha, Meizhu Xiao, Huiqiao Gao, Dongyan Cao, Jiaxin Yang, Jie Chen, Yue Wang, Zhenyu Zhang, Keng Shen

Published Feb 6, 2016 · Vol. 7, No. 13 · pp. 15566-15576

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial Research Paper

Khurum Khan, David Cunningham, Clare Peckitt, Sarah Barton, Diana Tait, Maria Hawkins, David Watkins, Naureen Starling, Sheela Rao, Ruwaida Begum, Janet Thomas, Jacqui Oates, Vincenza Guzzardo, Matteo Fassan, Chiara Braconi, Ian Chau

Published Feb 5, 2016 · Vol. 7, No. 11 · pp. 12672-12681

Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia Research Paper

Frida Ewald Sander, Anna RydstrÃ¶m, Elin Bernson, Roberta Kiffin, Rebecca Riise, Johan Aurelius, Harald Anderson, Mats Brune, Robin FoÃ, Kristoffer Hellstrand, Fredrik B. ThorÃ©n, Anna Martner

Published Feb 5, 2016 · Vol. 7, No. 7 · pp. 7586-7596

Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study Research Paper

Qingyang Feng, Ye Wei, Li Ren, Peng Zheng, Yiyi Yu, Qinghai Ye, Jianyong Ding, Jingwen Chen, Wenju Chang, Yunshi Zhong, Dexiang Zhu, Qi Lin, Liangliang Yang, Xinyu Qin, Jianmin Xu

Published Feb 4, 2016 · Vol. 7, No. 10 · pp. 11380-11396

Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy Research Paper

Takuya Asano, Yoshihiko Hirohashi, Toshihiko Torigoe, Tasuku Mariya, Ryota Horibe, Takafumi Kuroda, Yuta Tabuchi, Hiroshi Saijo, Kazuyo Yasuda, Masahito Mizuuchi, Akari Takahashi, Hiroko Asanuma, Tadashi Hasegawa, Tsuyoshi Saito, Noriyuki Sato

Published Feb 3, 2016 · Vol. 7, No. 10 · pp. 11223-11237

Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial Research Paper

Andrea Casadei Gardini, Silvia Carloni, Emanuela Scarpi, Paolo Maltoni, Romolo M. Dorizzi, Alessandro Passardi, Giovanni Luca Frassineti, Pietro Cortesi, Maria Benedetta Giannini, Giorgia Marisi, Dino Amadori, Alessandro Lucchesi

Published Feb 3, 2016 · Vol. 7, No. 9 · pp. 10193-10202

Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients Research Paper

Aleksandra Butrym, Justyna Rybka, Dagmara BaczyÅ„ska, RafaÅ‚ PorÄ™ba, Kazimierz Kuliczkowski, Grzegorz Mazur

Published Feb 3, 2016 · Vol. 7, No. 21 · pp. 30250-30257

CEST theranostics: label-free MR imaging of anticancer drugs Priority Research Paper

Yuguo Li, Hanwei Chen, Jiadi Xu, Nirbhay N. Yadav, Kannie W. Y. Chan, Liangping Luo, Michael T. McMahon, Bert Vogelstein, Peter C.M. van Zijl, Shibin Zhou, Guanshu Liu

Published Feb 2, 2016 · Vol. 7, No. 6 · pp. 6369-6378

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients Research Paper

Sarah Cattin, BenoÃ®t Fellay, Sylvain Pradervand, Andreas Trojan, Thomas Ruhstaller, Curzio RÃ¼egg, Gregor FÃ¼rstenberger

Published Jan 31, 2016 · Vol. 7, No. 10 · pp. 11137-11150

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer Priority Research Paper

Juliet D. French, Sharon E. Johnatty, Yi Lu, Jonathan Beesley, Bo Gao, Murugan Kalimutho, Michelle J. Henderson, Amanda J. Russell, Siddhartha Kar, Xiaoqing Chen, Kristine M. Hillman, Susanne Kaufmann, Haran Sivakumaran, Martin Oâ€™Reilly, Chen Wang, Darren J. Korbie, Australian Ovarian Cancer Study Group, Australian Cancer Study, Diether Lambrechts, Evelyn Despierre, Els Van Nieuwenhuysen, Sandrina Lambrechts, Ignace Vergote, Beth Karlan, Jenny Lester, Sandra Orsulic, Christine Walsh, Peter A. Fasching, Matthias W. Beckmann, Arif B. Ekici, Alexander Hein, Keitaro Matsuo, Satoyo Hosono, Jacobus Pisterer, Peter Hillemanns, Toru Nakanishi, Yasushi Yatabe, Marc T. Goodman, Galina Lurie, Rayna K. Matsuno, Pamela J. Thompson, Tanja Pejovic, Yukie Bean, Florian Heitz, Philipp Harter, Andreas du Bois, Ira Schwaab, Estrid Hogdall, Susanne K. Kjaer, Allan Jensen, Claus Hogdall, Lene Lundvall, Svend Aage Engelholm, Bob Brown, James M. Flanagan, Michelle D. Metcalf, Nadeem Siddiqui, Thomas Sellers, Brooke Fridley, Julie Cunningham, Joellen M. Schildkraut, Ed Iversen, Rachel Palmieri Weber, Donal Brennan, Andrew Berchuck, Paul Pharoah, Paul Harnett, Murray D. Norris, Michelle Haber, Ellen L. Goode, Jason S. Lee, Kum Kum Khanna, Kerstin B. Meyer, Georgia Chenevix-Trench, Anna deFazio, Stacey L. Edwards, Stuart MacGregor, on behalf of the Ovarian Cancer Association Consortium

Published Jan 31, 2016 · Vol. 7, No. 6 · pp. 6353-6368

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups Research Paper

Xiangyu Li, Hao Cai, Weicheng Zheng, Mengsha Tong, Hongdong Li, Lu Ao, Jing Li, Guini Hong, Mengyao Li, Qingzhou Guan, Sheng Yang, Da Yang, Xu Lin, Zheng Guo

Published Jan 30, 2016 · Vol. 7, No. 8 · pp. 8743-8755

KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies Research Paper

Wei Pan, Yan Yang, Hongcheng Zhu, Youcheng Zhang, Rongping Zhou, Xinchen Sun

Published Jan 30, 2016 · Vol. 7, No. 7 · pp. 8373-8388

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine Research Paper

Cheng Wang, Biao Liu, Xuelian Xu, Bo Zhuang, Hongxia Li, Jiaqi Yin, Mengyi Cong, Wei Xu, Aiping Lu

Published Jan 29, 2016 · Vol. 7, No. 7 · pp. 8360-8372

Distinguishing epigenetic features of preneoplastic testis tissues adjacent to seminomas and nonseminomas Research Paper

Ildar V. Gainetdinov, Sofia A. Kondratieva, Yulia V. Skvortsova, Marina V. Zinovyeva, Elena A. Stukacheva, Alexey Klimov, Alexey A. Tryakin, Tatyana L. Azhikina

Published Jan 29, 2016 · Vol. 7, No. 16 · pp. 22439-22447

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer Priority Research Paper

James DuHadaway, George C. Prendergast

Published Jan 28, 2016 · Vol. 7, No. 7 · pp. 7372-7380

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer? Research Paper

Valentin DerangÃ¨re, Jean David Fumet, Romain Boidot, Leila Bengrine, Emeric Limagne, AngÃ©lique Chevriaux, Julie Vincent, Sylvain Ladoire, Lionel Apetoh, CÃ©dric RÃ©bÃ©, FranÃ§ois Ghiringhelli

Published Jan 25, 2016 · Vol. 7, No. 8 · pp. 9309-9321

A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function Research Paper

Gang Chen, Junhua Liu, Wantao Chen, Qin Xu, Meng Xiao, Lihong Hu, Li Mao, Xu Wang

Published Jan 25, 2016 · Vol. 7, No. 8 · pp. 9388-9403

Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics Research Paper

Deyao Xie, Xiaoyi Wu, Linhua Lan, Fugeng Shangguan, Xiaoming Lin, Fuhong Chen, Shan Xu, Ya Zhang, Zilei Chen, Kate Huang, Rongrong Wang, Lu Wang, Xiaoxiao Song, Yongzhang Liu, Bin Lu

Published Jan 25, 2016 · Vol. 7, No. 10 · pp. 11609-11624

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells Research Paper

Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis Research Paper

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study Research Paper

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial Research Paper

Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia Research Paper

Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study Research Paper

Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy Research Paper

Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial Research Paper

Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients Research Paper

CEST theranostics: label-free MR imaging of anticancer drugs Priority Research Paper

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients Research Paper

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer Priority Research Paper

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups Research Paper

KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies Research Paper

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine Research Paper

Distinguishing epigenetic features of preneoplastic testis tissues adjacent to seminomas and nonseminomas Research Paper

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer Priority Research Paper

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer? Research Paper

A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function Research Paper

Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells Research Paper

Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis Research Paper

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study Research Paper

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial Research Paper

Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia Research Paper

Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study Research Paper

Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy Research Paper

Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial Research Paper

Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients Research Paper

CEST theranostics: label-free MR imaging of anticancer drugs Priority Research Paper

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients Research Paper

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer Priority Research Paper

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups Research Paper

KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies Research Paper

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine Research Paper

Distinguishing epigenetic features of preneoplastic testis tissues adjacent to seminomas and nonseminomas Research Paper

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer Priority Research Paper

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer? Research Paper

A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function Research Paper

Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics Research Paper